(Q40182427)

18 September 2017

1 reference

title

Physiologic pharmacokinetic models: relevance, experience, and future trends (English)

1 reference

18 September 2017

1 reference

Rowland M

1

1 reference

18 September 2017

language of work or name

English

0 references

publication date

1 January 1984

1 reference

18 September 2017

published in

Drug Metabolism Reviews

1 reference

18 September 2017

volume

15

1 reference

18 September 2017

issue

1-2

1 reference

18 September 2017

page(s)

55-74

1 reference

Lidocaine Pharmacokinetics in Advanced Heart Failure, Liver Disease, and Renal Failure in Humans

18 September 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F03602538409015057

Thiopental Pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602538409015057

Pharmacokinetics and bioavailability of prednisone and prednisolone in healthy volunteers and patients: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602538409015057

Estimation of tissue-to-plasma partition coefficients used in physiological pharmacokinetic models

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602538409015057

Factors affecting drug metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602538409015057

A study of factors influencing drug disposition in chronic liver disease, using the model drug (+)-propranolol

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602538409015057

Effect of Altered Plasma Protein Binding on Apparent Volume of Distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602538409015057

Clearance concepts in pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602538409015057

Influence of route of administration on drug availability

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602538409015057

Influence of First-Pass Effect on Availability of Drugs on Oral Administration

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602538409015057

Hepatic clearance of drugs. I. Theoretical considerations of a "well-stirred" model and a "parallel tube" model. Influence of hepatic blood flow, plasma and blood cell binding, and the hepatocellular enzymatic activity on hepatic drug clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602538409015057

Commentary: a physiological approach to hepatic drug clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602538409015057

A review of the applications of physiologically based pharmacokinetic modeling

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602538409015057

Hepatic elimination of flowing substrates: the distributed model

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602538409015057

Hepatic clearance of drugs. II. Experimental evidence for acceptance of the “well-stirred” model over the “parallel tube” model using lidocaine in the perfused rat liverin situ preparation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602538409015057

The kinetics of methotrexate distribution in spontaneous canine lymphosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602538409015057

Preliminary Model for Methotrexate Pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602538409015057

Effect of Plasma Protein Binding on Elimination of Warfarin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602538409015057

10.3109/03602538409015057

21 January 2018

Identifiers

DOI

1 reference

18 September 2017

1 reference